Once-Weekly TransCon® CNP (Navepegritide) Receives Positive CHMP Opinion for the Treatment of Achondroplasia in Children
Go back to Once-Weekly TransCon® CNP (Navepegritide) Receives Positive CHMP Opinion for the Treatment of Achondroplasia in Children| Asianada, Inc. (NASDAQ: ASND) | Delayed: 240.87 +1.97 (0.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $238.90 | 52 Week High | $21.79 | |||
| Open | $239.38 | 52 Week Low | $11.92 | |||
| Day High | $242.18 | P/E | N/A | |||
| Day Low | $236.87 | EPS | $-0.07 | |||
| Volume | 139,106 | |||||



